REIMAGINING T-CELL ENGINEERING to unlock the promise of immunotherapy A treatment approach with the potential to transform patient outcomes Vittoria Biotherapeutics is a clinical-stage company with a novel platform technology, Senza5, that powers a pipeline of highly differentiated immunotherapies designed to address unmet clinical needs in oncology and immunology. NEXT-GENERATION, ENABLED-AUTOLOGOUS CAR T-CELL THERAPIES Our […]